Joint Action on Vaccination (EU-JAV) (2018-2022)

EU-JAV started in September 2018 and will run until March 2022 with an aim to strengthen the cooperation between European countries to fight vaccine-preventable diseases. Its objective is to deliver and share concrete tools for stronger national responses to vaccination challenges such as vaccine hesitancy.

EU-JAV involves 20 European countries, the European Commission and several other stakeholders such as the European Centre for Disease Prevention and Control (ECDC), the World Health Organization (WHO) Europe, the European Medicines Agency (EMA) and the Standing Committee of European Doctors (CPME). The joint action is coordinated by the French National Institute for Health and Medical Research (Inserm). The work is structured in eight work packages:

• WP1: Coordination

• WP2: Dissemination

• WP3: Evaluation

• WP4: Integration in National Policies and Sustainability

• WP5: Immunisation Information Services to Strengthen Surveillance of Vaccine Coverage

• WP6: Vaccine Supply and Preparedness

• WP7: Vaccine Research and Development Priority-Setting Framework

• WP8: Vaccine Hesitancy and Uptake

CPME is a member of the stakeholder forum of the joint action. Please find the EU-JAV website here.